American Society of Hematology

August 10-13, 2014
The Broadmoor, Colorado Springs, Colorado

The ASH® Meeting on Lymphoma Biology is focused on basic and translational research in lymphoma and lymphoid malignancies. The goal of the meeting is to further the understanding of lymphoma pathogenesis and accelerate new therapies by providing a forum for scientific exchange and by developing a roadmap for lymphoma research. The meeting's objectives include:

  • Establish a forum for the exchange of the state-of-science in basic and translational lymphoma research
  • Encourage networking among lymphoma researchers to enable more collaboration and synergy in the field
  • Foster collaboration and sharing of data and reagents among lymphoma researchers
  • Support relationships between academia and industry focused on chemical biology, immunotherapy, and other therapeutic approaches in the area of lymphoma
  • Establish a roadmap for lymphoma research to inform funding agencies and the public

The target audience for this meeting includes laboratory-based scientists, translational investigators, pharmaceutical scientists, and others interested in lymphoma science. The three-day meeting will include didactic sessions, abstract presentations, and interactive workshops/panel discussions.

Registration Rates

Registration CategoryOn-Site Rate
(August 10-13)
Non-Member$1,100
ASH Member$650
ASH Associate and Student/Resident Member$150
Non-Member in Training1$250
Honorary and Emeritus Members2$0

1Non-member residents and fellows are required to provide a signed letter from their program director on their institution’s letterhead, which states that the registrant is currently enrolled in a training program. Registrants will have an opportunity to upload an electronic copy of the letter during the online registration process or provide a hard copy when registering on site.

2ASH Emeritus and Honorary members should contact the ASH Customer Relations Department at 866-828-1231 (International callers dial 011+1+202-776-0544) or email customerservice@hematology.org to register.

To cancel your registration and to request a refund, email customerservice@hematology.org. If your request is received by the cancellation deadline, July 27, you will receive a refund minus a $25 processing fee. Refund requests will not be accepted after the cancelation deadline.

Keynote Speaker:

Klaus Rajewsky, MD
Immune Regulation and Cancer
The Max Delbrück Center for Molecular Medicine, Berlin, Germany

Confirmed Speakers:

  • Ash Alizadeh, MD, PhD
    Stanford University, Stanford, CA
  • Renier J. Brentjens, MD, PhD
    Memorial Sloan-Kettering Cancer Center, New York, NY
  • John Byrd, MD
    The Ohio State University
  • Leandro Cerchietti, MD
    Weill Cornell Medical College, New York, NY
  • Jason Cyster, PhD
    University of California - San Francisco, San Francisco, CA
  • Riccardo Dalla Favera, MD
    Columbia University Medical Center, New York, NY
  • Chi Dang, MD, PhD
    University of Pennsylvania, Philadelphia, PA
  • Martin Dreyling, MD
    Ludwig-Maximilians University, Munich Germany
  • Adolfo Ferrando, MD, PhD
    Columbia University, New York, NY
  • Jonathan Freidberg, MD
    University of Rochester, Rochester, NY
  • Randy Gascoyne, MD
    British Columbia Cancer Agency, Vancouver, Canada
  • Giorgio G. Inghirami, MD
    Weill Cornell Medical College, New York, NY
  • Ralf Küppers, PhD
    University of Duisberg-Essen, Essen, Germany
  • Ron Levy, MD
    Stanford University School of Medicine, Stanford, CA
  • Tak Mak, PhD
    Princess Margaret Hospital, Toronto, Canada
  • Ari Melnick, MD
    Weill Cornell Medical College, New York, NY
  • Bertrand Nadel, PhD
    Centre D'Immunologie De Marseille-Luminy, Marseille, France
  • Laura Pasqualucci, MD
    Institute for Cancer Genetic, Columbia University, New York, NY
  • Kerry Savage, MD
    BC Cancer Agency, Vancouver, Canada
  • Clemens Schmitt, MD
    Max-Delbruck Center for Molecular Medicine, Berlin, Germany
  • Margaret Shipp, MD
    Dana-Farber Cancer Institute, Boston, MA
  • Lou Staudt, MD, PhD
    NCI, NIH, Bethesda, MD
  • Margot Thome, PhD
    University of Lausanne, Switzerland
  • David Weinstock, MD
    Dana-Farber Cancer Institute, Boston, MA
  • Irving Weissman, MD
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA
  • Hans-Guido Wendel, MD
    Memorial Sloan-Kettering Cancer Center, New York, NY
  • Wyndham Wilson, MD, PhD
    NCI, NIH, Bethesda, MD
  • Catherine Wu, MD
    Dana-Farber Cancer Institute, Boston, MA

Steering Committee:

Co-Chairs:

  • Ari Melnick, MD
    Weill Cornell Medical College, New York, NY
  • Louis Staudt, MD, PhD
    NCI, NIH, Bethesda, MD
  • David Weinstock, MD
    Dana-Farber Cancer Institute, Boston, MA

Committee Members:

  • Riccardo Dalla-Favera, MD
    Columbia University, New York, NY
  • Randy Gascoyne, MD
    British Columbia Cancer Agency, Vancouver, Canada
  • John Leonard, MD
    Weill Cornell Medical College, New York, NY
  • Ronald Levy, MD
    Stanford University, Stanford, CA
  • Izidore Lossos, MD
    University of Miami, Miami, FL
  • Grzegorz Nowakowski, MD
    Mayo Clinic, Rochester, MN
  • Oliver Press, MD, PhD
    Fred Hutchinson Research Center, Seattle, WA
  • Kerry Savage, MD
    British Columbia Cancer Agency, Vancouver, Canada
  • Margaret Shipp, MD
    Dana-Farber Cancer Institute, Boston, MA

Government Concierge

ASH understands that Federal agencies within the U.S. government are adjusting and developing new guidelines for conference attendance for their employees, and that each Agency will have their own policy. Therefore, ASH has established a Government Concierge to assist interested persons with information that will help them with their attendance request and application. If there is information needed for your application for funding approval that you cannot locate on the ASH website, you may send an email to the ASH Government Concierge for assistance.

ASH will be providing the following meals as part of the registration fee for the conference:

  • Sunday - light hor d'oeuvre at the Opening Reception
  • Monday - breakfast, lunch, and dinner
  • Tuesday - breakfast and lunch
  • Wednesday - breakfast

Attendees are on their own for a non-hosted dinner on Tuesday evening. Since the meeting ends at mid-day on Wednesday, there is no lunch provided.

The Government Concierge will also make its best effort to assist Federal employees in finding available hotel rooms in the Colorado Springs area that offer the government per diem rate. ASH suggests that this be done well in advance and, if possible, when your application for funding approval is submitted.  

Accreditation

The American Society of Hematology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Hematology designates this live activity for a maximum of 19AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with their participation in the activity.

Corporate Support

The American Society of Hematology would like to acknowledge the following companies for the educational grants provided in support of the 2014 ASH Meeting on Lymphoma Biology.

Premier Supporter

  • Millennium: The Takeda Oncology Company

Lead Supporter

  • Celgene
  • Pharmacyclics
  • Teva Oncology

General

  • AbbVie
  • Dana Farber Cancer Institute
  • Illumina, Inc.
  • Leukemia & Lymphoma Society
  • Lymphoma Research Foundation

Additional Information

Join a mailing list to receive email about important news and updates on the upcoming Lymphoma Biology meeting.

For more information on abstracts and speakers, please contact:
ASHMLB@hematology.org.

For information about corporate support, please contact:
development@hematology.org.

Please submit all general inquiries to:
meetings@hematology.org.

back to top